IWO tracks an index of US small-cap growth stocks, selected from those ranked 1001-3000 by market-cap based on growth factors.
GKOS: Q2 sales surged 50% year-over-year, led by iDose TR and Epioxa, with guidance raised to $680M–$700M
Glaukos (NYSE:GKOS) Posts Quarterly Earnings Results, Beats Expectations By $0.07 EPS
Glaukos Q2 2026 earnings preview
Glaukos | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 185.61 M
US High Growth Tech Stocks To Watch In July 2026
Glaukos (NYSE:GKOS) Shares Up 7.6% - Here's What Happened